BOLT Financials
Bolt Biotherapeutics - Financial statements & key metrics
Stock Price
$4.07
Market Cap
$11.33M
P/E Ratio
-2.5
EPS
$-22.21
Income Statement Highlights
Most Recent Quarter: 2024-12-31
Revenue
$7.69M
Gross Profit
-
Operating Income
-
Net Income
$-63.12M
EPS (Diluted)
$-1.65
Balance Sheet Highlights
Total Assets
$99.63M
Total Liabilities
$42.43M
Shareholders Equity
-
Cash & Equivalents
$7.21M
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
$-61.29M
CapEx
-
Free Cash Flow
-
Profitability Metrics
Operating Margin
-355.1%
ROE
-82.0%
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is BOLT revenue?
BOLT's most recent quarterly revenue was $7.69M. Annual revenue can be calculated by summing the four most recent quarters.
Is BOLT profitable?
BOLT reported a loss of $63.12M in the most recent quarter.
What is BOLT market cap?
BOLT has a market capitalization of $11.33M, making it a small-cap stock.
Does BOLT have debt?
View BOLT's balance sheet for debt information.
What is BOLT cash flow?
Cash flow data is available in the full financial statements.